Peralta, Baby Girl -.

HRN: 21-99-98  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
AMPICILLIN 1GM (VIAL)
11/27/2022
12/04/2022
IV
155mg
Q12
Thickly MSAF
Waiting Final Action 
11/27/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/27/2022
12/04/2022
IV
47mg
OD
Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: